info@synchemia.com | sales@synchemia.com 
9766925136 
Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Candesartan Benzimidazole Ethoxy Methyl Ester
| CAT No | SRC-N0142691 |
| CAS No | NA |
| Mol.F. | C11H11N3O4 |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Cilexetil EP Impurity A
| CAT No | SRC-N0142692 |
| CAS No | NA |
| Mol.F. | C26H23N7O4 |
| Mol.Wt. | 497.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Cilexetil EP Impurity C
| CAT No | SRC-N0142694 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Cilexetil EP Impurity D
| CAT No | SRC-N0142695 |
| CAS No | NA |
| Mol.F. | C33H33N7O7 |
| Mol.Wt. | 639.67 g/mol |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso Candesartan Cilexetil EP Impurity G
| CAT No | SRC-N0142696 |
| CAS No | NA |
| Mol.F. | C24H19N7O4 |
| Mol.Wt. | 469.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Cilexetil EP Impurity I
| CAT No | SRC-N0142697 |
| CAS No | NA |
| Mol.F. | C25H21N7O4 |
| Mol.Wt. | 483.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan PGI-5 Impurity
| CAT No | SRC-N0142698 |
| CAS No | NA |
| Mol.F. | C23H18N4O5 |
| Mol.Wt. | 430.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Acid Methoxy Analog
| CAT No | SRC-N0142699 |
| CAS No | NA |
| Mol.F. | C23H17N7O4 |
| Mol.Wt. | 455.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Benzimidazole Methoxy Methyl Ester
| CAT No | SRC-N0142700 |
| CAS No | NA |
| Mol.F. | C10H9N3O4 |
| Mol.Wt. | 235.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Cilexetil Methoxy Analog
| CAT No | SRC-N0142701 |
| CAS No | NA |
| Mol.F. | C32H31N7O7 |
| Mol.Wt. | 625.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Candesartan Desethyl Analog
| CAT No | SRC-N0142702 |
| CAS No | NA |
| Mol.F. | C22H15N7O4 |
| Mol.Wt. | 441.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diazoxide
| CAT No | SRC-N0142703 |
| CAS No | NA |
| Mol.F. | C8H6ClN3O3S |
| Mol.Wt. | 259.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso Diazoxide Benzothiadiazinone Analog (USP)
| CAT No | SRC-N0142704 |
| CAS No | NA |
| Mol.F. | C7H4ClN3O4S |
| Mol.Wt. | 261.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diazoxide Impurity 2
| CAT No | SRC-N0142705 |
| CAS No | NA |
| Mol.F. | C8H9N3O4S |
| Mol.Wt. | 243.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diazoxide Impurity 3
| CAT No | SRC-N0142706 |
| CAS No | NA |
| Mol.F. | C8H7ClN2O5S |
| Mol.Wt. | 278.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Mepivacaine
| CAT No | SRC-N0142707 |
| CAS No | NA |
| Mol.F. | C15H21N3O2 |
| Mol.Wt. | 275.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
